-
-
-
-
-
-
-
Acer Therapeutics (ACER) call put ratio 4.2 calls to 1 put
-
-
-
-
-
-
-
Revance Therapeutics (RVNC) Announces FDA Acceptance of sBLA for DAXXIFY
-
-
-
-
-
-
-
Pfizer (PFE) Announces FDA Acceptance for Priority Review of sBLA for 20vPnC
-
-
-
-
-
-
-
Acer Therapeutics (ACER) calls more active than puts
-
-
-
-
-
-
-
Acer Therapeutics (ACER) 30-day option implied volatility at 122
-
-
-
-
-
-
-
Coherus (CHRS) and Junshi Have not Received Action Letter from FDA on toripalimab in combination with chemotherapy
-
-
-
-
-
-
-
Sarepta Therapeutics (SRPT) PT Raised to $160 at BTIG 'on Our Conviction on SRP-9001's FDA Approval'
-
10,555 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All